158 related articles for article (PubMed ID: 34974662)
21. Influence of Trichomonas vaginalis macrophage migration inhibitory factor on the proliferation activity of prostate epithelial cell line and its preliminary mechanism.
Lin L; Xia S; Zhang W; Chen S
Andrologia; 2022 Jun; 54(5):e14397. PubMed ID: 35191055
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Seropositivity to Trichomonas vaginalis between Men with Prostatic Tumor and Normal Men.
Kim JH; Moon HS; Kim KS; Hwang HS; Ryu JS; Park SY
Korean J Parasitol; 2019 Feb; 57(1):21-25. PubMed ID: 30840795
[TBL] [Abstract][Full Text] [Related]
23. Trichomonas vaginalis inhibits proinflammatory cytokine production in macrophages by suppressing NF-kappaB activation.
Chang JH; Ryang YS; Morio T; Lee SK; Chang EJ
Mol Cells; 2004 Oct; 18(2):177-85. PubMed ID: 15528993
[TBL] [Abstract][Full Text] [Related]
24. Molecular Examination of
Kamarkhani Z; Rafiei-Sefiddashti R; Haghighi L; Badirzadeh A; Hadighi R
Ethiop J Health Sci; 2021 Mar; 31(2):237-240. PubMed ID: 34158774
[TBL] [Abstract][Full Text] [Related]
25. Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study.
Saleh NE; Alhusseiny SM; El-Zayady WM; Aboelnaga EM; El-Beshbishi WN; Saleh YM; Abou-ElWafa HS; El-Beshbishi SN
Parasitol Res; 2021 Apr; 120(4):1379-1388. PubMed ID: 33159459
[TBL] [Abstract][Full Text] [Related]
26.
Arana-Argáez VE; Ceballos-Góngora E; Alvarez-Sánchez ME; Euan-Canto A; Lara-Riegos J; Torres-Romero JC
Immunol Invest; 2022 Jan; 51(1):88-102. PubMed ID: 32838604
[TBL] [Abstract][Full Text] [Related]
27. Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race/ethnicity in the PLCO Trial.
Marous M; Huang WY; Rabkin CS; Hayes RB; Alderete JF; Rosner B; Grubb RL; Winter AC; Sutcliffe S
Cancer Causes Control; 2017 Aug; 28(8):889-898. PubMed ID: 28669054
[TBL] [Abstract][Full Text] [Related]
28. Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease risk.
Langston ME; Bhalla A; Alderete JF; Nevin RL; Pakpahan R; Hansen J; Elliott D; De Marzo AM; Gaydos CA; Isaacs WB; Nelson WG; Sokoll LJ; Zenilman JM; Platz EA; Sutcliffe S
Prostate; 2019 Oct; 79(14):1622-1628. PubMed ID: 31376187
[TBL] [Abstract][Full Text] [Related]
29. Involvement of mast cells in inflammation induced by Trichomonas vaginalis via crosstalk with vaginal epithelial cells.
Han IH; Park SJ; Ahn MH; Ryu JS
Parasite Immunol; 2012 Jan; 34(1):8-14. PubMed ID: 21981317
[TBL] [Abstract][Full Text] [Related]
30. Cytokine array analysis of mediators produced by human macrophages stimulated with Trichomonastenax.
Motes HC; Stuart MK
Exp Parasitol; 2022 Nov; 242():108382. PubMed ID: 36122701
[TBL] [Abstract][Full Text] [Related]
31. Signalling pathways associated with IL-6 production and epithelial-mesenchymal transition induction in prostate epithelial cells stimulated with Trichomonas vaginalis.
Han IH; Kim JH; Kim SS; Ahn MH; Ryu JS
Parasite Immunol; 2016 Nov; 38(11):678-687. PubMed ID: 27543848
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis of macrophages induced by Trichomonas vaginalis through the phosphorylation of p38 mitogen-activated protein kinase that locates at downstream of mitochondria-dependent caspase activation.
Chang JH; Kim SK; Choi IH; Lee SK; Morio T; Chang EJ
Int J Biochem Cell Biol; 2006; 38(4):638-47. PubMed ID: 16360334
[TBL] [Abstract][Full Text] [Related]
33. Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer.
Chen YC; Huang YL; Platz EA; Alderete JF; Zheng L; Rider JR; Kraft P; Giovannucci E; Sutcliffe S
Cancer Causes Control; 2013 Jan; 24(1):175-80. PubMed ID: 23179660
[TBL] [Abstract][Full Text] [Related]
34. Reduced
Barajas-Mendiola MA; Castellano LE; Barrios-Rodiles M; Deveze-Alvarez MA; Avila EE; Cuéllar-Mata P
Parasitology; 2019 Nov; 146(13):1636-1645. PubMed ID: 31391128
[TBL] [Abstract][Full Text] [Related]
35. Involvement of MAP kinases in apoptosis of macrophage treated with Trichomonas vaginalis.
Ryang YS; Chang JH; Park JY
Yonsei Med J; 2004 Aug; 45(4):751-4. PubMed ID: 15344222
[TBL] [Abstract][Full Text] [Related]
36. Immune Response of BALB/c Mice toward Putative Calcium Transporter Recombinant Protein of Trichomonas vaginalis.
Mendoza-Oliveros T; Arana-Argáez V; Alvaréz-Sánchez LC; Lara-Riegos J; Alvaréz-Sánchez ME; Torres-Romero JC
Korean J Parasitol; 2019 Feb; 57(1):33-38. PubMed ID: 30840797
[TBL] [Abstract][Full Text] [Related]
37. Trichomonas vaginalis: a possible foe to prostate cancer.
Zhu Z; Davidson KT; Brittingham A; Wakefield MR; Bai Q; Xiao H; Fang Y
Med Oncol; 2016 Oct; 33(10):115. PubMed ID: 27613161
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cells induce specific cytotoxic T lymphocytes against prostate cancer TRAMP-C2 cells loaded with freeze- thaw antigen and PEP-3 peptide.
Liu XQ; Jiang R; Li SQ; Wang J; Yi FP
Asian Pac J Cancer Prev; 2015; 16(2):571-8. PubMed ID: 25684489
[TBL] [Abstract][Full Text] [Related]
39. Trichomonas vaginalis Induces NLRP3 Inflammasome Activation and Pyroptotic Cell Death in Human Macrophages.
Riestra AM; Valderrama JA; Patras KA; Booth SD; Quek XY; Tsai CM; Nizet V
J Innate Immun; 2019; 11(1):86-98. PubMed ID: 30391945
[TBL] [Abstract][Full Text] [Related]
40. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.
Stark JR; Judson G; Alderete JF; Mundodi V; Kucknoor AS; Giovannucci EL; Platz EA; Sutcliffe S; Fall K; Kurth T; Ma J; Stampfer MJ; Mucci LA
J Natl Cancer Inst; 2009 Oct; 101(20):1406-11. PubMed ID: 19741211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
